146 related articles for article (PubMed ID: 38361704)
1. Comparison of Remotely Applied and Face-to-Face Disease Activity Scores in Saudi Arabian Patients With Rheumatoid Arthritis: A Prospective Cohort Study.
Almansouri AY; Alsofyani R; Alharbi HA; Almaqati AS; Aloqbi HS; Bakhsh L; Althubaiti A; Alzahrani Z
Cureus; 2024 Jan; 16(1):e52390. PubMed ID: 38361704
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Disease Activity Scores and Routine Assessment of Patient Index Data (RAPID3) on a Multidimensional Health Assessment Questionnaire in Patients With Rheumatoid Arthritis: A Saudi Experience.
Abdulaziz S; Almaqati AS; Komo K; Alahmadi A
Cureus; 2023 Sep; 15(9):e44982. PubMed ID: 37822428
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Disease Activity Score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation.
Kumar BS; Suneetha P; Mohan A; Kumar DP; Sarma KVS
Indian J Med Res; 2017 Nov; 146(Supplement):S57-S62. PubMed ID: 29578196
[TBL] [Abstract][Full Text] [Related]
4. The RAPID3 questionnaire as a screening tool to reduce the number of outpatient clinic visits: a retrospective cohort study.
Wiegel J; Seppen BF; Ter Wee MM; Nurmohamed MT; Boers M; Bos WH
Clin Rheumatol; 2022 Aug; 41(8):2525-2531. PubMed ID: 35469354
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and its correlation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience.
Singh H; Gupta V; Ray S; Kumar H; Talapatra P; Kaur M; Kumar S; Arya S; Mathur R; Ghangas N
Clin Rheumatol; 2012 Dec; 31(12):1663-9. PubMed ID: 22983768
[TBL] [Abstract][Full Text] [Related]
6. Performance of routine assessment of patient index data 3 (RAPID3) in monitoring disease activity of Chinese rheumatoid arthritis patients.
Zhang X; Xie A; Wang Y; Deng X; Geng Y; Ji L; Hao Y; Li G; Zhang Z
Int J Rheum Dis; 2018 Nov; 21(11):1940-1945. PubMed ID: 30402934
[TBL] [Abstract][Full Text] [Related]
7. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories.
Pincus T; Swearingen CJ; Bergman M; Yazici Y
J Rheumatol; 2008 Nov; 35(11):2136-47. PubMed ID: 18793006
[TBL] [Abstract][Full Text] [Related]
8. Performance of Routine Assessment of Patient Index Data 3 (RAPID3) for assessment of rheumatoid arthritis in clinical practice: differential agreement of RAPID3 according to disease activity categories.
Kim SK; Park SH; Bae J; Son JT; Choe JY
Rheumatol Int; 2014 Sep; 34(9):1311-8. PubMed ID: 24832679
[TBL] [Abstract][Full Text] [Related]
9. RAPID3 (Routine Assessment of Patient Index Data) on an MDHAQ (Multidimensional Health Assessment Questionnaire): agreement with DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) activity categories, scored in five versus more than ninety seconds.
Pincus T; Swearingen CJ; Bergman MJ; Colglazier CL; Kaell AT; Kunath AM; Siegel EL; Yazici Y
Arthritis Care Res (Hoboken); 2010 Feb; 62(2):181-9. PubMed ID: 20191516
[TBL] [Abstract][Full Text] [Related]
10. Routine Assessment of Patient Index Data 3 (RAPID3) alone is insufficient to monitor disease activity in rheumatoid arthritis in clinical practice.
Boone NW; Sepriano A; van der Kuy PH; Janknegt R; Peeters R; Landewé RBM
RMD Open; 2019; 5(2):e001050. PubMed ID: 31908842
[TBL] [Abstract][Full Text] [Related]
11. RAPID3 (Routine Assessment of Patient Index Data 3) severity categories and response criteria: Similar results to DAS28 (Disease Activity Score) and CDAI (Clinical Disease Activity Index) in the RAPID 1 (Rheumatoid Arthritis Prevention of Structural Damage) clinical trial of certolizumab pegol.
Pincus T; Furer V; Keystone E; Yazici Y; Bergman MJ; Luijtens K
Arthritis Care Res (Hoboken); 2011 Aug; 63(8):1142-9. PubMed ID: 21485024
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.
Son KM; Kim SY; Lee SH; Yang CM; Seo YI; Kim HA
Int J Rheum Dis; 2016 Dec; 19(12):1278-1283. PubMed ID: 26200604
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the DAS28-CRP and DAS28-ESR in patients with rheumatoid arthritis.
Sengul I; Akcay-Yalbuzdag S; Ince B; Goksel-Karatepe A; Kaya T
Int J Rheum Dis; 2015 Jul; 18(6):640-5. PubMed ID: 26013310
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Disease Activity Metrics in a Methotrexate Withdrawal Study among Patients with Rheumatoid Arthritis Treated with Tofacitinib plus Methotrexate.
Fleischmann R; Haraoui B; Buch MH; Gold D; Sawyerr G; Shi H; Diehl A; Lee K
Rheumatol Ther; 2023 Apr; 10(2):375-386. PubMed ID: 36534208
[TBL] [Abstract][Full Text] [Related]
15. Evaluating patient reported outcomes in routine practice of patients with rheumatoid arthritis treated with biological disease modifying anti rheumatic drugs (b-DMARDs).
Boone NW; Teeuwisse P; van der Kuy PH; Janknegt R; Landewé RB
Springerplus; 2015; 4():462. PubMed ID: 26339563
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of feet and ankle arthritis and their impact on clinical indices in patients with rheumatoid arthritis: a cross-sectional study.
Lee SW; Kim SY; Chang SH
BMC Musculoskelet Disord; 2019 Sep; 20(1):420. PubMed ID: 31506089
[TBL] [Abstract][Full Text] [Related]
17. Routine Assessment of Patient Index Data 3 (RAPID3) in Patients with Rheumatoid Arthritis Treated with Long-Term Upadacitinib Therapy in Five Randomized Controlled Trials.
Bergman M; Buch MH; Tanaka Y; Citera G; Bahlas S; Wong E; Song Y; Zueger P; Ali M; Strand V
Rheumatol Ther; 2022 Dec; 9(6):1517-1529. PubMed ID: 36125701
[TBL] [Abstract][Full Text] [Related]
18. Thresholds for the 28-joint disease activity score (DAS28) using C-reactive protein are lower compared to DAS28 using erythrocyte sedimentation rate in early rheumatoid arthritis.
Kuriya B; Schieir O; Lin D; Xiong J; Pope J; Boire G; Haraoui B; Thorne JC; Tin D; Hitchon C; Jamal S; Keystone E; Bykerk VP;
Clin Exp Rheumatol; 2017; 35(5):799-803. PubMed ID: 28339365
[TBL] [Abstract][Full Text] [Related]
19. Proposed severity and response criteria for Routine Assessment of Patient Index Data (RAPID3): results for categories of disease activity and response criteria in abatacept clinical trials.
Pincus T; Hines P; Bergman MJ; Yazici Y; Rosenblatt LC; MacLean R
J Rheumatol; 2011 Dec; 38(12):2565-71. PubMed ID: 22089467
[TBL] [Abstract][Full Text] [Related]
20. Validity and Agreement between the 28-Joint Disease Activity Score Based on C-Reactive Protein and Erythrocyte Sedimentation Rate in Patients with Rheumatoid Arthritis.
Nielung L; Christensen R; Danneskiold-Samsøe B; Bliddal H; Holm CC; Ellegaard K; Slott Jensen H; Bartels EM
Arthritis; 2015; 2015():401690. PubMed ID: 25632353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
